Nicola Biagio Mercuri

Nicola Biagio Mercuri's AcademicInfluence.com Rankings

Biology

#9246

World Rank

#12429

Historical Rank

Neuroscience

#1339

World Rank

#1385

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Nicola Biagio Mercuri Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Nicola Biagio Mercuri's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia (1996) (464)
Long‐term Potentiation in the Striatum is Unmasked by Removing the Voltage‐dependent Magnesium Block of NMDA Receptor Channels (1992) (404)
Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease. (1993) (319)
Abnormal Synaptic Plasticity in the Striatum of Mice Lacking Dopamine D2 Receptors (1997) (294)
Intracellular studies on the dopamine-induced firing inhibition of neostriatal neurons in vitro: Evidence for D1 receptor involvement (1987) (267)
Presynaptic Facilitation of Glutamatergic Synapses to Dopaminergic Neurons of the Rat Substantia Nigra by Endogenous Stimulation of Vanilloid Receptors (2003) (254)
Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer's disease (2017) (247)
Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease. (2014) (231)
Loss of autoreceptor function in dopaminergic neurons from dopamine D2 receptor deficient mice. (1997) (226)
Coactivation of D1 and D2 dopamine receptors is required for long-term synaptic depression in the striatum (1992) (212)
The 'magic' of L-dopa: why is it the gold standard Parkinson's disease therapy? (2005) (211)
Properties of the Hyperpolarization‐activated Cation Current lh in Rat Midbrain Dopaminergic Neurons (1995) (206)
Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene (2001) (165)
Synaptic and intrinsic control of membrane excitability of neostriatal neurons. I. An in vivo analysis. (1990) (163)
N-Arachidonoyl-Dopamine Tunes Synaptic Transmission onto Dopaminergic Neurons by Activating both Cannabinoid and Vanilloid Receptors (2007) (161)
The dopamine-containing neuron: maestro or simple musician in the orchestra of addiction? (2003) (159)
Effects of dihydropyridine calcium antagonists on rat midbrain dopaminergic neurones (1994) (156)
Obstructive Sleep Apnea is Associated With Early but Possibly Modifiable Alzheimer’s Disease Biomarkers Changes (2017) (151)
Review: Parkinson's disease: from synaptic loss to connectome dysfunction (2016) (146)
Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection (2020) (146)
Responses of intracellularly recorded cortical neurons to the iontophoretic application of dopamine (1982) (140)
A Critical Interaction between Dopamine D2 Receptors and Endocannabinoids Mediates the Effects of Cocaine on Striatal GABAergic Transmission (2004) (138)
Activation of TRPV1 in the VTA Excites Dopaminergic Neurons and Increases Chemical- and Noxious-Induced Dopamine Release in the Nucleus Accumbens (2005) (134)
Inflammation Subverts Hippocampal Synaptic Plasticity in Experimental Multiple Sclerosis (2013) (132)
Increased persistent sodium current determines cortical hyperexcitability in a genetic model of amyotrophic lateral sclerosis (2009) (130)
Involvement of transient receptor potential‐like channels in responses to mGluR‐I activation in midbrain dopamine neurons (2003) (129)
Riluzole interacts with voltage-activated sodium and potassium currents in cultured rat cortical neurons (1998) (118)
Dysbiosis of gut microbiota in a selected population of Parkinson's patients. (2019) (112)
Blockade of Nociceptin/Orphanin FQ Receptor Signaling in Rat Substantia Nigra Pars Reticulata Stimulates Nigrostriatal Dopaminergic Transmission and Motor Behavior (2004) (110)
Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease (2019) (109)
Dopamine decreases cell excitability in rat striatal neurons by pre- and postsynaptic mechanisms (1985) (102)
Action of GP 47779, the Active Metabolite of Oxcarbazepine, on the Corticostriatal System. II. Modulation of High‐Voltage‐Activated Calcium Currents (1995) (101)
Temperature sensitivity of dopaminergic neurons of the substantia nigra pars compacta: involvement of transient receptor potential channels. (2005) (101)
Activation of quisqualate metabotropic receptors reduces glutamate and GABA-mediated synaptic potentials in the rat striatum (1992) (99)
Intrinsic membrane properties and synaptic inputs regulating the firing activity of the dopamine neurons (2002) (98)
On the mechanisms underlying hypoxia-induced membrane depolarization in striatal neurons. (1995) (98)
l-DOPA: A scapegoat for accelerated neurodegeneration in Parkinson's disease? (2011) (96)
Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia (2010) (93)
Paraquat-and Rotenone-Induced Models of Parkinson's Disease (2011) (92)
L-Type Calcium Channels Mediate a Slow Excitatory Synaptic Transmission in Rat Midbrain Dopaminergic Neurons (1998) (88)
Targeting Synaptic Dysfunction in Alzheimer’s Disease Therapy (2012) (85)
Transient receptor potential‐like channels mediate metabotropic glutamate receptor EPSCs in rat dopamine neurones (2004) (82)
The electrophysiological actions of dopamine and dopaminergic drugs on neurons of the substantia nigra pars compacta and ventral tegmental area. (1992) (81)
Vulnerability of Medium Spiny Striatal Neurons to Glutamate: Role of Na+/K+ ATPase (1995) (81)
Increased levels of d-aspartate in the hippocampus enhance LTP but do not facilitate cognitive flexibility (2008) (80)
Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's disease (2016) (80)
Dopamine modulates CA1 hippocampal neurons by elevating the threshold for spike generation: An in vitro study (1984) (79)
Chronic neuroleptic treatment: D2 dopamine receptor supersensitivity and striatal glutamatergic transmission (1992) (79)
Acute action of rotenone on nigral dopaminergic neurons – involvement of reactive oxygen species and disruption of Ca2+ homeostasis (2009) (78)
Treatment of the symptoms of Huntington's disease: Preliminary results comparing aripiprazole and tetrabenazine (2009) (77)
Cu/Zn-superoxide dismutase (GLY93→ALA) mutation alters AMPA receptor subunit expression and function and potentiates kainate-mediated toxicity in motor neurons in culture (2004) (77)
Lamotrigine derivatives and riluzole inhibit INa,P in cortical neurons (2002) (75)
Endogenous dopamine and dopaminergic agonists modulate synaptic excitation in neostriatum: Intracellular studies from naive and catecholamine-depleted rats (1988) (71)
Group I metabotropic glutamate receptors mediate an inward current in rat substantia nigra dopamine neurons that is independent from calcium mobilization. (1999) (70)
Activation of metabotropic glutamate receptors induces an inward current in rat dopamine mesencephalic neurons (1993) (69)
Heterogeneity of Metabotropic Glutamate Receptors in the Striatum: Electrophysiological Evidence (1993) (68)
Interleukin-1β Promotes Long-Term Potentiation in Patients with Multiple Sclerosis (2014) (66)
Increased d-aspartate brain content rescues hippocampal age-related synaptic plasticity deterioration of mice (2011) (65)
Synaptic Plasticity and PDGF Signaling Defects Underlie Clinical Progression in Multiple Sclerosis (2013) (64)
Dietary Vitamin E as a Protective Factor for Parkinson's Disease: Clinical and Experimental Evidence (2019) (63)
Metabotropic Glutamate Receptor 1 Mediates the Electrophysiological and Toxic Actions of the Cycad Derivative β-N-Methylamino-l-Alanine on Substantia Nigra Pars Compacta DAergic Neurons (2010) (61)
Effect of Memantine on Resting State Default Mode Network Activity in Alzheimer’s Disease (2011) (61)
Dysfunctional dopaminergic neurotransmission in asocial BTBR mice (2014) (60)
Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer’s disease (2016) (60)
Glutamate Metabotropic Receptor Agonists Depress Excitatory and Inhibitory Transmission on Rat Mesencephalic Principal Neurons (1997) (60)
Role of Aberrant Striatal Dopamine D1 Receptor/cAMP/Protein Kinase A/DARPP32 Signaling in the Paradoxical Calming Effect of Amphetamine (2010) (59)
Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction (2019) (59)
Persistent increase of d-aspartate in d-aspartate oxidase mutant mice induces a precocious hippocampal age-dependent synaptic plasticity and spatial memory decay (2011) (59)
The role of dopaminergic midbrain in Alzheimer's disease: Translating basic science into clinical practice (2018) (58)
Synaptic plasticity, dopamine and Parkinson's disease: one step ahead. (2008) (58)
Synaptic and intrinsic control of membrane excitability of neostriatal neurons. II. An in vitro analysis. (1990) (58)
Muscarinic receptors depress GABAergic synaptic transmission in rat midbrain dopamine neurons (2000) (57)
Insulin Receptor β-Subunit Haploinsufficiency Impairs Hippocampal Late-Phase LTP and Recognition Memory (2012) (57)
Altered cortico‐striatal synaptic plasticity and related behavioural impairments in reeler mice (2006) (57)
Therapeutic potential of targeting hydrogen peroxide metabolism in the treatment of brain ischaemia (2012) (57)
Whole cell patch-clamp recordings of rat midbrain dopaminergic neurons isolate a sulphonylurea- and ATP-sensitive component of potassium currents activated by hypoxia. (1998) (57)
Action of GP 47779, the Active Metabolite of Oxcarbazepine, on the Corticostriatal System. I. Modulation of Corticostriatal Synaptic Transmission (1995) (57)
Systemic Activation of Nrf2 Pathway in Parkinson's Disease (2020) (56)
Cognitive Impairment and Dentate Gyrus Synaptic Dysfunction in Experimental Parkinsonism (2014) (55)
Self-reported needs of patients with Parkinson’s disease during COVID-19 emergency in Italy (2020) (55)
Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology (2019) (55)
Responses of rat substantia nigra compacta neurones to L‐DOPA (1990) (54)
Effects of anoxia on rat midbrain dopamine neurons. (1994) (54)
Actions of methylphenidate on dopaminergic neurons of the ventral midbrain (2005) (54)
Transcranial magnetic stimulation predicts cognitive decline in patients with Alzheimer’s disease (2018) (54)
Rotigotine may improve sleep architecture in Parkinson's disease: a double-blind, randomized, placebo-controlled polysomnographic study. (2016) (54)
Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: Role of Na+/K+ ATPase (2006) (53)
The mechanism of amphetamine‐induced inhibition of rat substantia nigra compacta neurones investigated with intracellular recording in vitro (1989) (53)
Sleep-disordered breathing and the risk of Alzheimer's disease. (2020) (52)
Early structural and functional plasticity alterations in a susceptibility period of DYT1 dystonia mouse striatum (2018) (52)
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? (2016) (51)
Continuous Positive Airway Pressure Treatment Increases Serum Vitamin D Levels in Male Patients with Obstructive Sleep Apnea. (2015) (51)
Endogenous GABA mediates presynaptic inhibition of spontaneous and evoked excitatory synaptic potentials in the rat neostriatum (1990) (50)
Electrophysiological actions of felbamate on rat striatal neurones (1995) (49)
In vivo mapping of brainstem nuclei functional connectivity disruption in Alzheimer's disease (2018) (48)
Presynaptic inhibition of gamma-aminobutyric acidB-mediated synaptic current by adenosine recorded in vitro in midbrain dopamine neurons. (1995) (48)
From Traumatic Childhood to Cocaine Abuse: The Critical Function of the Immune System (2018) (48)
Preserved fronto-striatal plasticity and enhanced procedural learning in a transgenic mouse model of Alzheimer's disease overexpressing mutant hAPPswe. (2004) (48)
Molecular and synaptic changes in the hippocampus underlying superior spatial abilities in pre-symptomatic G93A+/+ mice overexpressing the human Cu/Zn superoxide dismutase (Gly93 → ALA) mutation (2006) (47)
Inhibitory effects of trace amines on rat midbrain dopaminergic neurons (2004) (47)
Effects of riluzole on rat cortical neurones: an in vitro electrophysiological study (1997) (47)
Felbamate inhibits dihydropyridine-sensitive calcium channels in central neurons. (1996) (46)
Presynaptic muscarinic (M3) receptors reduce excitatory transmission in dopamine neurons of the rat mesencephalon (1999) (46)
Acute effects of 6-hydroxydopamine on dopaminergic neurons of the rat substantia nigra pars compacta in vitro. (2005) (46)
Group I metabotropic glutamate receptors activate burst firing in rat midbrain dopaminergic neurons (2002) (45)
Over-expression of N-type calcium channels in cortical neurons from a mouse model of Amyotrophic Lateral Sclerosis (2013) (45)
Altered calcium homeostasis in motor neurons following AMPA receptor but not voltage-dependent calcium channels’ activation in a genetic model of amyotrophic lateral sclerosis (2007) (44)
Posterior Reversible Encephalopathy Syndrome after Hematopoietic Cell Transplantation in Children with Hemoglobinopathies. (2017) (44)
Evidence of hydrogen sulfide involvement in amyotrophic lateral sclerosis (2015) (44)
Ethanol enhances GABAB‐mediated inhibitory postsynaptic transmission on rat midbrain dopaminergic neurons by facilitating GIRK currents (2009) (44)
Epileptiform discharge induced by 4-aminopyridine in magnesium-free medium in neocortical neurons: physiological and pharmacological characterization (1997) (44)
Chronic Cocaine Prevents Depotentiation at Corticostriatal Synapses (2006) (44)
Free D-aspartate regulates neuronal dendritic morphology, synaptic plasticity, gray matter volume and brain activity in mammals (2014) (44)
Is autonomic nervous system involved in restless legs syndrome during wakefulness? (2014) (43)
Lithium Treatment Blocks Long-Term Synaptic Depression in the Striatum (1993) (43)
Group I mGluRs coupled to G proteins are regulated by tyrosine kinase in dopamine neurons of the rat midbrain. (2001) (42)
Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors (2007) (42)
Calcineurin Inhibition Rescues Early Synaptic Plasticity Deficits in a Mouse Model of Alzheimer’s Disease (2013) (42)
Heart rate variability in untreated newly diagnosed temporal lobe epilepsy: Evidence for ictal sympathetic dysregulation (2016) (42)
Profile of gantenerumab and its potential in the treatment of Alzheimer’s disease (2013) (42)
Neurotensin induces an inward current in rat mesencephalic dopaminergic neurons (1993) (42)
Cognitive rehabilitation post traumatic brain injury: A systematic review for emerging use of virtual reality technology (2019) (42)
PINK1 heterozygous mutations induce subtle alterations in dopamine‐dependent synaptic plasticity (2014) (42)
Dopamine loss alters the hippocampus-nucleus accumbens synaptic transmission in the Tg2576 mouse model of Alzheimer's disease (2018) (41)
Current Concepts on the Physiopathological Relevance of Dopaminergic Receptors (2017) (41)
miR-34b/c Regulates Wnt1 and Enhances Mesencephalic Dopaminergic Neuron Differentiation (2018) (41)
LTP-like cortical plasticity is associated with verbal memory impairment in Alzheimer's disease patients (2019) (41)
On the properties of identified dopaminergic neurons in the mouse substantia nigra and ventral tegmental area (2017) (41)
Dystonia as a network disorder: a concept in evolution (2018) (41)
α-amino-3-hydroxy-5-methyl-isoxazole-4-propionate receptors in spinal cord motor neurons are altered in transgenic mice overexpressing human Cu,Zn superoxide dismutase (Gly93→Ala) mutation (2003) (40)
Physical Activity Changes and Correlate Effects in Patients with Parkinson's Disease during COVID‐19 Lockdown (2020) (40)
Obstructive sleep apnea may induce orexinergic system and cerebral β-amyloid metabolism dysregulation: is it a further proof for Alzheimer's disease risk? (2019) (39)
Transmitter Release Associated with Long‐term Synaptic Depression in Rat Corticostriatal Slices (1995) (39)
Amyloid-Mediated Cholinergic Dysfunction in Motor Impairment Related to Alzheimer's Disease. (2018) (39)
A voltage-clamp analysis of NMDA-induced responses on dopaminergic neurons of the rat subtantia nigra zona compacta and ventral tegmental area (1992) (39)
Excessive and precocious glutamate release in a mouse model of amyotrophic lateral sclerosis (2004) (39)
Sleep disorders in myotonic dystrophy type 2: a controlled polysomnographic study and self‐reported questionnaires (2014) (39)
Presynaptic c-Jun N-terminal Kinase 2 regulates NMDA receptor-dependent glutamate release (2015) (38)
Rapid constitutive and ligand‐activated endocytic trafficking of P2X3 receptor (2009) (38)
Oxidative stress in stroke pathophysiology validation of hydrogen peroxide metabolism as a pharmacological target to afford neuroprotection. (2009) (38)
A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices (1996) (37)
Dopaminergic dysfunction is associated with IL-1β-dependent mood alterations in experimental autoimmune encephalomyelitis (2015) (37)
RGS9‐2 rescues dopamine D2 receptor levels and signaling in DYT1 dystonia mouse models (2018) (37)
Alpha1-adrenoceptor-mediated excitation of substantia nigra pars reticulata neurons (2000) (37)
Monoamine Oxidase Inhibition Causes a Long-Term Prolongation of the Dopamine-Induced Responses in Rat Midbrain Dopaminergic Cells (1997) (37)
Efficacy and tolerability of perampanel and levetiracetam as first add-on therapy in patients with epilepsy: A retrospective single center study (2018) (37)
Altered long-term corticostriatal synaptic plasticity in transgenic mice overexpressing human CU/ZN superoxide dismutase (GLY93→ALA) mutation (2003) (36)
Intracellular sodium and calcium homeostasis during hypoxia in dopamine neurons of rat substantia nigra pars compacta. (1998) (36)
CSF beta‐amyloid levels are altered in narcolepsy: a link with the inflammatory hypothesis? (2014) (36)
Reelin haploinsufficiency reduces the density of PV+ neurons in circumscribed regions of the striatum and selectively alters striatal-based behaviors (2009) (36)
Dual effects of l-DOPA on nigral dopaminergic neurons (2013) (35)
Distinct mechanisms of presynaptic inhibition at GABAergic synapses of the rat substantia nigra pars compacta. (2005) (35)
GABA depolarizes neurons in the rat striatum: An in vivo study (1991) (35)
Centrality of Early Synaptopathy in Parkinson’s Disease (2018) (35)
(-)-Linalool attenuates allodynia in neuropathic pain induced by spinal nerve ligation in c57/bl6 mice. (2009) (34)
Sleep-Wake Cycle in Alzheimer's Disease Is Associated with Tau Pathology and Orexin Dysregulation. (2020) (34)
Selective depression of synaptic transmission by tetanus toxin: A comparative study on hippocampal and neostriatal slices (1989) (34)
Cellular localization of TRPC3 channel in rat brain: preferential distribution to oligodendrocytes (2004) (34)
Electrical stimulation of mesencephalic cell groups (A9-A10) produces monosynaptic excitatory potentials in rat frontal cortex (1985) (33)
Neuregulin 1 signalling modulates mGluR1 function in mesencephalic dopaminergic neurons (2014) (33)
Effects of zonisamide as add-on therapy on sleep-wake cycle in focal epilepsy: A polysomnographic study (2013) (33)
Identification of distinct cellular pools of interleukin-1β during the evolution of the neuroinflammatory response induced by transient middle cerebral artery occlusion in the brain of rat (2010) (33)
Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer’s disease course (2020) (32)
Kainate‐induced currents in rat cortical neurons in culture are modulated by riluzole (2002) (32)
Donepezil modulates nicotinic receptors of substantia nigra dopaminergic neurones (2004) (32)
Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer’s disease (2017) (32)
Exposure to low-dose rotenone precipitates synaptic plasticity alterations in PINK1 heterozygous knockout mice (2016) (31)
The blockade of K(+)-ATP channels has neuroprotective effects in an in vitro model of brain ischemia. (2007) (31)
Phosphodiesterase 10A controls D1-mediated facilitation of GABA release from striato-nigral projections under normal and dopamine-depleted conditions (2014) (30)
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis (2016) (30)
Firing properties and functional connectivity of substantia nigra pars compacta neurones recorded with a multi‐electrode array in vitro (2010) (30)
Cocaine dependence and stroke: pathogenesis and management. (2015) (30)
Trace Amines Depress GABAB Response in Dopaminergic Neurons by Inhibiting G-βγ-Gated Inwardly Rectifying Potassium Channels (2005) (30)
Pharmacological identification of the K+ currents mediating the hypoglycemic hyperpolarization of rat midbrain dopaminergic neurones (2000) (30)
Astrocyte-Dependent Vulnerability to Excitotoxicity in Spermine Oxidase-Overexpressing Mouse (2016) (29)
Assessment of Motor Impairments in Early Untreated Parkinson's Disease Patients: The Wearable Electronics Impact (2020) (29)
Memantine Inhibits ATP-Dependent K+ Conductances in Dopamine Neurons of the Rat Substantia Nigra Pars Compacta (2007) (28)
Sleep apnoeas may represent a reversible risk factor for amyloid-β pathology. (2017) (28)
Synaptic plasticity in the basal ganglia: A similar code for physiological and pathological conditions (2008) (28)
Learning discloses abnormal structural and functional plasticity at hippocampal synapses in the APP23 mouse model of Alzheimer's disease. (2010) (28)
Adenosine A1 receptor stimulation reduces D1 receptor-mediated GABAergic transmission from striato-nigral terminals and attenuates l-DOPA-induced dyskinesia in dopamine-denervated mice (2014) (27)
Functional alterations of the dopaminergic and glutamatergic systems in spontaneous α-synuclein overexpressing rats (2017) (27)
Young-onset and late-onset Parkinson's disease exhibit a different profile of fluid biomarkers and clinical features (2020) (27)
Dopamine-dependent early synaptic and motor dysfunctions induced by α-synuclein in the nigrostriatal circuit (2021) (27)
CSF α-synuclein inversely correlates with non-motor symptoms in a cohort of PD patients. (2019) (27)
Vitamin D status of male OSAS patients improved after long-term CPAP treatment mainly in obese subjects. (2017) (26)
On the Modulatory Roles of Neuregulins/ErbB Signaling on Synaptic Plasticity (2019) (26)
Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis (2010) (26)
Protective role of hydrogen peroxide in oxygen‐deprived dopaminergic neurones of the rat substantia nigra (2005) (26)
Persistent elevation of D-Aspartate enhances NMDA receptor-mediated responses in mouse substantia nigra pars compacta dopamine neurons (2016) (26)
Gamma-hydroxybutyrate and ethanol depress spontaneous excitatory postsynaptic currents in dopaminergic neurons of the substantia nigra (2004) (26)
Serotonin Impairment in CSF of PD Patients, without an Apparent Clinical Counterpart (2014) (26)
Cerebrospinal-fluid orexin levels and daytime somnolence in frontotemporal dementia (2014) (26)
Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population (2016) (25)
Safinamide effect on sleep disturbances and daytime sleepiness in motor fluctuating Parkinson's disease patients: A validated questionnaires-controlled study. (2018) (25)
Effect of P2 purinoceptor antagonists on kainate-induced currents in rat cultured neurons (2000) (25)
Ambra1 Shapes Hippocampal Inhibition/Excitation Balance: Role in Neurodevelopmental Disorders (2018) (25)
Distinct modulation of the endocannabinoid system upon kainic acid-induced in vivo seizures and in vitro epileptiform bursting (2014) (25)
Daytime sleepiness may be an independent symptom unrelated to sleep quality in Parkinson’s disease (2019) (24)
Optic Nerve Dysfunction in Obstructive Sleep Apnea: An Electrophysiological Study. (2016) (24)
Presynaptic Modulation of Spontaneous Inhibitory Postsynaptic Currents by Gamma-hydroxybutyrate in the Substantia Nigra Pars Compacta (2004) (24)
When Cognitive Decline and Depression Coexist in the Elderly: CSF Biomarkers Analysis Can Differentiate Alzheimer's Disease from Late-Life Depression (2018) (24)
Phospho-S129 Alpha-Synuclein Is Present in Human Plasma but Not in Cerebrospinal Fluid as Determined by an Ultrasensitive Immunoassay (2019) (24)
Nilotinib restores memory function by preventing dopaminergic neuron degeneration in a mouse model of Alzheimer’s Disease (2021) (23)
Exercise interventions in Alzheimer’s disease: A systematic review and meta-analysis of randomized controlled trials (2021) (23)
Levels of amyloid-beta-42 and CSF pressure are directly related in patients with Alzheimer’s disease (2017) (23)
Glutamate spillover drives endocannabinoid production and inhibits GABAergic transmission in the Substantia Nigra pars compacta (2014) (23)
Electrophysiological evidence for the presence of ionotropic and metabotropic excitatory amino acid receptors on dopaminergic neurons of the rat mesencephalon: an in vitro study. (1992) (23)
Trace amines depress D2‐autoreceptor‐mediated responses on midbrain dopaminergic cells (2010) (23)
Neuropsychiatric symptoms differently affect mild cognitive impairment and Alzheimer’s disease patients: a retrospective observational study (2019) (22)
The modulation of calcium currents by the activation of mGluRs (1996) (22)
The weaver Mutation Reverses the Function of Dopamine and GABA in Mouse Dopaminergic Neurons (2000) (22)
Loss of striatal cannabinoid CB1 receptor function in attention‐deficit / hyperactivity disorder mice with point‐mutation of the dopamine transporter (2011) (22)
Hypoglycemia enhances ionotropic but reduces metabotropic glutamate responses in substantia nigra dopaminergic neurons. (2001) (22)
The role of adiponectin receptors in the regulation of synaptic transmission in the hippocampus (2017) (21)
Neuroprotective effects of riluzole: An electrophysiological and histological analysis in an in vitro model of ischemia (1999) (21)
Electrophysiological and amperometric evidence that modafinil blocks the dopamine uptake transporter to induce behavioral activation (2013) (21)
Sleep disorders in spinal and bulbar muscular atrophy (Kennedy’s disease): a controlled polysomnographic and self-reported questionnaires study (2014) (21)
Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine‐related drugs on rat midbrain dopaminergic neurons (1999) (21)
Effect of segmental muscle vibration on upper extremity functional ability poststroke (2019) (21)
Responses of rat mesencephalic dopaminergic neurons to a prolonged period of oxygen deprivation (1994) (21)
An electrophysiological analysis of the protective effects of felbamate, lamotrigine, and lidocaine on the functional recovery from in vitro ischemia in rat neocortical slices (1998) (20)
Substantia nigra control of basal ganglia nuclei. (2009) (20)
Role of lifestyle factors on plasma homocysteine levels in Parkison's disease patients treated with levodopa (2006) (20)
Voltage‐activated sodium currents in a cell line expressing a Cu,Zn superoxide dismutase typical of familial ALS (1998) (20)
Beta-amyloid and phosphorylated tau metabolism changes in narcolepsy over time (2016) (20)
Chemical modulation of synaptic transmission in the striatum. (1993) (20)
On the Effects of Psychostimulants, Antidepressants, and the Antiparkinsonian Drug Levodopa on Dopamine Neurons (2006) (20)
The P2Y4 receptor forms homo-oligomeric complexes in several CNS and PNS neuronal cells (2006) (20)
Cerebral blood volume lesion extent predicts functional outcome in patients with vertebral and basilar artery occlusion (2019) (20)
Hypoxia-Induced Electrical Changes in Striatal Neurons (1995) (19)
Paradoxical Abatement of Striatal Dopaminergic Transmission by Cocaine and Methylphenidate* (2013) (19)
Depletion of catecholamines reveals inhibitory effects of bromocryptine and lysuride on neostriatal neurones recorded intracellularly in vitro (1988) (19)
Neuroprotective actions in vivo and electrophysiological actions in vitro of 202W92 (2001) (19)
Effects of glycine on neurons in the rat substantia nigra zona compacta: In vitro electrophysiological study (1990) (19)
The action of glycine on rat epileptic foci (1981) (18)
Glutamate receptor stimulation induces a persistent rhythmicity of the GABAergic inputs to rat midbrain dopaminergic neurons (2001) (18)
Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients (2021) (18)
Protective Role of Cerebrospinal Fluid Inflammatory Cytokines in Patients with Amnestic Mild Cognitive Impairment and Early Alzheimer's Disease Carrying Apolipoprotein E4 Genotype. (2020) (18)
N-Glycans mutations rule oligomeric assembly and functional expression of P2X3 receptor for extracellular ATP. (2011) (18)
Changes in spasticity following functional electrical stimulation cycling in patients with spinal cord injury: A systematic review (2020) (17)
A continuous high frequency stimulation of the subthalamic nucleus determines a suppression of excitatory synaptic transmission in nigral dopaminergic neurons recorded in vitro (2012) (17)
Lacosamide may improve cognition in patients with focal epilepsy: EpiTrack to compare cognitive side effects of lacosamide and carbamazepine (2018) (17)
Physical Exercise and Alzheimer’s Disease: Effects on Pathophysiological Molecular Pathways of the Disease (2021) (17)
Association between physical activity and dementia’s risk factors in patients with Parkinson’s disease (2019) (17)
Cognitive performances in patients affected by late-onset epilepsy with unknown etiology: A 12-month follow-up study (2019) (17)
Cerebrospinal Fluid Orexin Levels and Nocturnal Sleep Disruption in Alzheimer's Disease Patients Showing Neuropsychiatric Symptoms. (2018) (17)
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study. (2019) (17)
Nomifensine but not amantadine increases dopamine-induced responses on rat substantia nigra zona compacta neurons (1991) (17)
Enhanced mu opioid receptor–dependent opioidergic modulation of striatal cholinergic transmission in DYT1 dystonia (2018) (17)
Dopamine selectively reduces GABAB transmission onto dopaminergic neurones by an unconventional presynaptic action (2002) (17)
Trace amines reduce GABAB receptor-mediated presynaptic inhibition at GABAergic synapses of the rat substantia nigra pars compacta (2005) (16)
N-Methyl-d-aspartate receptors mediate a slow excitatory postsynaptic potential in the rat midbrain dopaminergic neurons (1996) (16)
Electrophysiological effects of monoamine oxidase inhibition on rat midbrain dopaminergic neurones: an in vitro study (1996) (16)
A2A Adenosine Receptor Antagonism Enhances Synaptic and Motor Effects of Cocaine via CB1 Cannabinoid Receptor Activation (2012) (16)
Restless legs syndrome and post polio syndrome: a case−control study (2015) (16)
Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons (2011) (16)
Effects of Phenobarbital and Levetiracetam on PR and QTc Intervals in Patients with Post-Stroke Seizure (2014) (16)
Clinical value of CSF amyloid-beta-42 and tau proteins in Progressive Supranuclear Palsy (2018) (16)
The l-amino acid carrier inhibitor 2-aminobicyclo[2.2.1]heptane-2-carboxylic acid (BCH) reduces l-dopa-elicited responses in dopaminergic neurons of the substantia nigra pars compacta (2008) (15)
Hippocampus versus entorhinal cortex decoupling by an NR2 subunit–specific block of NMDA receptors in a rat in vitro model of temporal lobe epilepsy (2012) (15)
A-current in rat globus pallidus: A whole-cell voltage clamp study on acutely dissociated neurons (1992) (15)
Preliminary evidence that vortioxetine may improve sleep quality in depressed patients with insomnia: a retrospective questionnaire analysis (2018) (15)
Evaluation of the psychometric properties of the Barthel Index in an Italian ischemic stroke population in the acute phase: a cross-sectional study. (2019) (15)
Voltage-gated calcium channels mediate intracellular calcium increase in weaver dopaminergic neurons during stimulation of D2 and GABAB receptors. (2004) (15)
Potassium ions play a role in the glycine-induced inhibition of rat substantia nigra zona compacta neurones (1988) (15)
Electrophysiological pharmacology of the autoreceptor-mediated responses of dopaminergic cells to antiparkinsonian drugs. (1997) (15)
Proteomics and Toxicity Analysis of Spinal-Cord Primary Cultures upon Hydrogen Sulfide Treatment (2018) (15)
Effective treatment of restless legs syndrome by safinamide in Parkinson's disease patients. (2018) (15)
Daytime autonomic activity in idiopathic rapid eye movement sleep behavior disorder: a preliminary study. (2018) (14)
Hippocampal epileptogenesis in autoimmune encephalitis (2019) (14)
Dopamine-containing neurons are silenced by energy deprivation: a defensive response or beginning of cell death? (2005) (14)
Ischemic injury precipitates neuronal vulnerability in Parkinson's disease: Insights from PINK1 mouse model study and clinical retrospective data. (2020) (14)
Rhythmic auditory stimulation in gait rehabilitation for traumatic brain and spinal cord injury (2019) (14)
Differential effect of carbamazepine and oxcarbazepine on excitatory synaptic transmission in rat hippocampus (2008) (14)
Neuregulin 1/ErbB signalling modulates hippocampal mGluRI‐dependent LTD and object recognition memory (2018) (14)
Technology-Based Objective Measures Detect Subclinical Axial Signs in Untreated, de novo Parkinson's Disease. (2019) (14)
Modified age-dependent expression of NaV1.6 in an ALS model correlates with motor cortex excitability alterations (2019) (14)
Subtle alterations of excitatory transmission are linked to presynaptic changes in the hippocampus of PINK1‐deficient mice (2016) (14)
The Role of Topiramate in the Management of Cocaine Addiction: A Possible Therapeutic Option (2015) (14)
Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a Natural Population of Cognitive Intact Parkinson's Disease Patients. (2017) (13)
Behavioral, Neurochemical, and Electrophysiological Changes in an Early Spontaneous Mouse Model of Nigrostriatal Degeneration (2011) (13)
Pisa Syndrome in Parkinson's Disease: Evidence for Bilateral Vestibulospinal Dysfunction (2018) (13)
Physiology and pharmacology of dopamine D2‐receptors (1989) (13)
Acetylcholine-dopamine balance in striatum: is it still a target for antiparkinsonian therapy? (1989) (12)
Age-related changes of hippocampal synaptic plasticity in AβPP-null mice are restored by NGF through p75NTR. (2012) (12)
CSF Biomarkers for Early Diagnosis of Synucleinopathies: Focus on Idiopathic RBD (2019) (12)
Stimulation of δ Opioid Receptor and Blockade of Nociceptin/Orphanin FQ Receptor Synergistically Attenuate Parkinsonism (2014) (12)
Adherence to social distancing and use of personal protective equipment and the risk of SARS-CoV-2 infection in a cohort of patients with multiple sclerosis (2020) (12)
Selective disarrangement of the rostral telencephalic cholinergic system in heterozygous reeler mice (2007) (12)
Increase of Prokineticin‐2 in Serum of Patients with Parkinson's Disease (2021) (12)
Cerebellar White Matter Disruption in Alzheimer's Disease Patients: A Diffusion Tensor Imaging Study. (2020) (11)
Continuous Positive Airway Pressure Treatment May Improve Optic Nerve Function in Obstructive Sleep Apnea: An Electrophysiological Study. (2018) (11)
mGluR1-Dependent Long Term Depression in Rodent Midbrain Dopamine Neurons Is Regulated by Neuregulin 1/ErbB Signaling (2018) (11)
Subclinical cochlear dysfunction in newly diagnosed relapsing-remitting multiple sclerosis. (2019) (11)
Estrogen Deficiency Hampers the Beneficial Effect of Continuous Positive Airway Pressure Therapy on Serum Vitamin D Concentrations in Postmenopausal Women Affected by Obstructive Sleep Apnea. (2015) (11)
In vivo human molecular neuroimaging of dopaminergic vulnerability along the Alzheimer’s disease phases (2021) (11)
Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study (2019) (11)
Postural and vestibular changes related to CPAP treatment in moderate-to-severe OSA patients: a 12-month longitudinal study (2018) (11)
Optogenetic Activation of Striatopallidal Neurons Reveals Altered HCN Gating in DYT1 Dystonia. (2020) (11)
Autonomic symptoms, cardiovascular and sudomotor evaluation in de novo type 1 narcolepsy (2020) (10)
The modulation of dopamine receptors in rat striatum. (1995) (10)
Dopamine uptake inhibition potentiates the effects of l-DOPA on rat substantia nigra zona compacta neurons (1991) (10)
Impact of Pharmacological Inhibition of Hydrogen Sulphide Production in the SOD1G93A-ALS Mouse Model (2019) (10)
Properties of dopaminergic neurons in organotypic mesencephalic–striatal co‐cultures – evidence for a facilitatory effect of dopamine on the glutamatergic input mediated by α‐1 adrenergic receptors (2011) (10)
Rotigotine may control drooling in patients with Parkinson’s Disease: Preliminary findings (2017) (10)
Brain energy metabolism and neurodegeneration: hints from CSF lactate levels in dementias (2021) (10)
Trace amines depress GABA B response in dopaminergic neurons by inhibiting G-betagamma-gated inwardly rectifying potassium channels. (2005) (10)
Feasibility of automated detection of sleep apnea using implantable pacemakers and defibrillators: a comparison with simultaneous polysomnography recording (2019) (10)
Reversal of dopamine‐mediated firing inhibition through activation of the dopamine transporter in substantia nigra pars compacta neurons (2018) (9)
Resilience to anhedonia-passive coping induced by early life experience is linked to a long-lasting reduction of Ih current in VTA dopaminergic neurons (2021) (9)
May CSF beta-amyloid and tau proteins levels be influenced by long treatment duration and stable medication in narcolepsy? (2014) (9)
Resistance to striatal dopamine depletion induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice expressing human mutant Cu,Zn superoxide dismutase (2002) (9)
Oral l-carnitine as treatment for narcolepsy without cataplexy during pregnancy: A case report (2015) (9)
Thymomatous myasthenia gravis: novel association with HLA DQB1*05:01 and strengthened evidence of high clinical and serological severity (2019) (9)
Transient upregulation of translational efficiency in prodromal and early symptomatic Tg2576 mice contributes to Aβ pathology (2020) (9)
Serum prolactin levels in repetitive temporal epileptic seizures. (2008) (9)
Depressive and anxiety symptoms in patients with SARS-CoV2 infection (2020) (9)
The effect of postural deformities on back function and pain in patients with Parkinson's disease. (2019) (9)
Characterization of a Barium‐sensitive Outward Current following Glutamate Application on Rat Midbrain Dopaminergic Cells (1996) (9)
Familiar trajectories facilitate the interpretation of physical forces when intercepting a moving target (2014) (9)
Perampanel Increases Cortical EEG Fast Activity in Child and Adult Patients Affected by Epilepsy: A Quantitative EEG Study (2020) (9)
Symptomatic nonconvulsive status epilepticus erroneously suggestive of sporadic Creutzfeldt–Jakob disease (2015) (9)
Effective treatment of nocturnal frontal lobe epilepsy with lacosamide: a report of two cases. (2016) (9)
Sleep disorders and late-onset epilepsy of unknown origin: Understanding new trajectories to brain amyloidopathy (2021) (8)
Brain Functional Connectivity in de novo Parkinson's Disease Patients Based on Clinical EEG (2022) (8)
The anorexic agents, sibutramine and fenfluramine, depress GABAB‐induced inhibitory postsynaptic potentials in rat mesencephalic dopaminergic cells (2009) (8)
Chronic dopaminergic treatment in restless legs syndrome: does it affect the autonomic nervous system? (2015) (8)
Ventral tegmental area disconnection contributes two years early to correctly classify patients converted to Alzheimer’s disease: Implications for treatment (2021) (8)
Perampanel effectiveness and tolerability in patients with epilepsy at long-term follow-up (2021) (8)
Does Pisa syndrome affect upper limb function in patients with Parkinson's disease? An observational cross-sectional study. (2018) (8)
Tetrabenazine improves levodopa-induced peak-dose dyskinesias in patients with Parkinson's disease. (2013) (8)
The striatal-enriched protein Rhes is a critical modulator of cocaine-induced molecular and behavioral responses (2019) (8)
Author Correction: Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease (2019) (8)
Lipidomics of Bioactive Lipids in Alzheimer’s and Parkinson’s Diseases: Where Are We? (2022) (8)
Sleep problems affect quality of life in Parkinson's disease along disease progression. (2021) (8)
Frequency of Non-motor Symptoms in Parkinson's Patients With Motor Fluctuations (2021) (8)
Cognitive and Neuropsychiatric Profiles in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinson’s Disease (2021) (7)
Pathophysiological Features of Nigral Dopaminergic Neurons in Animal Models of Parkinson’s Disease (2022) (7)
Does continuous positive airway pressure treatment affect autonomic nervous system in patients with severe obstructive sleep apnea? (2017) (7)
3,4-Methylenedioxymethamphetamine (MDMA) Alters Synaptic Dopamine Release in the Dorsal Striatum Through Nicotinic Receptors and DAT Inhibition (2018) (7)
Comparison of the effectiveness and tolerability of perampanel and brivaracetam: a real-world, observational, retrospective study. (2020) (7)
Effects of Ultramicronized Palmitoylethanolamide (um-PEA) in COVID-19 Early Stages: A Case–Control Study (2022) (7)
Tissue degeneration in ALS affected spinal cord evaluated by Raman spectroscopy (2018) (7)
L-DOPA-quinone Mediated Recovery from GIRK Channel Firing Inhibition in Dopaminergic Neurons. (2019) (7)
Restless Legs Syndrome and Poliomyelitis: New Evidences of an Old Observation? (2015) (7)
Heart Rate Variability Parameters During Psychogenic Non-epileptic Seizures: Comparison Between Patients With Pure PNES and Comorbid Epilepsy (2020) (7)
Electroencephalography and dementia: a literature review and future perspectives. (2013) (7)
Dopamine hyperpolarizes neurons in the rat substantia nigra zona compacta in vitro by increasing potassium conductance (1986) (7)
The influence of postural deformities on neck function and pain in patients with Parkinson's disease. (2019) (7)
Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add‐on therapy compared to levetiracetam and valproic acid (2019) (7)
The Importance of Diagnosing and the Clinical Potential of Treating Obstructive Sleep Apnea to Delay Mild Cognitive Impairment and Alzheimer’s Disease: A Special Focus on Cognitive Performance (2021) (7)
Task-oriented Motor Learning in Upper Extremity Rehabilitation Post Stroke (2019) (7)
Modification of levodopa responses by deprenyl (selegiline): An electrophysiological and behavioral study in the rat relevant to Parkinson's disease (1998) (7)
Obstructive sleep apnea syndrome and Alzheimer’s disease pathology: may continuous positive airway pressure treatment delay cognitive deterioration? (2021) (6)
Dyspnea perception and neurological symptoms in non-severe COVID-19 patients (2020) (6)
Met- and leu-enkephalins inhibit rat cortical neurons intracellularly recorded in vivo while morphine excites them: evidence for naloxone-sensitive and naloxone-insensitive effects (2004) (6)
LONG-TERM CHANGES OF CORTICOSTRIATAL SYNAPTIC TRANSMISSION: POSSIBLE IMPLICATION FOR MOTOR MEMORY (1995) (6)
Electrophysiology of dopamine D-1 receptors in the basal ganglia: Old facts and new perspectives (1995) (6)
Facial diplegia resembling bilateral Ramsay Hunt Syndrome (2017) (6)
Insights on the Functional Interaction between Group 1 Metabotropic Glutamate Receptors (mGluRI) and ErbB Receptors (2020) (6)
Autonomic functions in focal epilepsy: A comparison between lacosamide and carbamazepine monotherapy (2020) (6)
Investigating Different Forms of Hydrogen Sulfide in Cerebrospinal Fluid of Various Neurological Disorders (2021) (6)
D‐Tubocurarine reduces GABA responses in rat substantia nigra dopamine neurons (2003) (6)
Action of morphine on rat cortical neurons intracellularly recorded in vivo: Evidence for an excitatory postsynaptic effect which is naloxone insensitive (1986) (6)
Potent T cell‐mediated anti‐inflammatory role of the selective CB2 agonist lenabasum in multiple sclerosis (2021) (6)
Treatment with Dimethyl Fumarate Enhances Cholinergic Transmission in Multiple Sclerosis (2018) (6)
Amyloid-β42/Neurogranin Ratio as a Potential Index for Cognitive Impairment in Parkinson's Disease. (2020) (5)
Methamidophos transiently inhibits neuronal nicotinic receptors of rat substantia nigra dopaminergic neurons via open channel block (2004) (5)
Attention Allocation to Financial Information: The Role of Color and Impulsivity Personality Trait (2019) (5)
Sudomotor and cardiovascular autonomic function in de novo Parkinson's disease assessed by sudoscan and cardiovascular reflexes (2021) (5)
Adult-onset sporadic chorea: real-world data from a single-centre retrospective study (2021) (5)
Effects of head trauma and sport participation in young-onset Parkinson’s disease (2021) (5)
Inhibition of hippocampal plasticity in rats performing contrafreeloading for water under repeated administrations of pramipexole (2016) (5)
Assessment of Hearing Impairment in Parkinson's Disease: Implications for Differential Diagnosis and Disease Progression (2017) (5)
Electrophysiologic Changes in Ventral Midbrain Dopaminergic Neurons Resulting from (+/−) -3,4-Methylenedioxymethamphetamine (MDMA—“Ecstasy”) (2007) (5)
Emerging Roles of Protease-Activated Receptors (PARs) in the Modulation of Synaptic Transmission and Plasticity (2021) (5)
Increased Noradrenaline as an Additional Cerebrospinal Fluid Biomarker in PSP-Like Parkinsonism (2020) (5)
Inhibition of cathecol-O-methyltransferase (COMT) in the brain does not affect the action of dopamine and levodopa: an in vitro electrophysiological evidence from rat mesencephalic dopamine neurons (1999) (5)
Physiological role of GABAb receptors in the mammalian neostriatum. (1992) (5)
Unilateral spatial neglect and alien limb phenomenon may be early features of Creutzfeldt-Jakob disease. (2013) (5)
Abnormal cervical lymph nodes in multiple sclerosis: a preliminary ultrasound study (2018) (4)
Actions of Glycine on Non‐dopaminergic Neurons of the Rat Substantia Nigra (1995) (4)
Restless legs syndrome and daytime sleepiness are prominent in myotonic dystrophy type 2 (2014) (4)
Development of Collateral Veins as a Favorable Prognostic Factor for Complete Recovery in Cerebral Venous Thrombosis Due to Tribulus Terrestris (2015) (4)
Biofluids profile of α-Klotho in patients with Parkinson's disease. (2021) (4)
Early Life Social Stress Causes Sex- and Region-Dependent Dopaminergic Changes that Are Prevented by Minocycline (2022) (4)
More than sleep and wake disturbances: An actigraphic study showing the sleep-wake pattern dysregulation in epilepsy (2021) (4)
Commentary: Clinical Correlates of Raphe Serotonergic Dysfunction in Early Parkinson’s Disease (2015) (4)
Laterality of Auditory Dysfunction in Parkinson's Disease (2020) (4)
TRPV1 polymorphisms and risk of interferon β-induced flu-like syndrome in patients with relapsing-remitting multiple sclerosis (2017) (4)
Patient’s point of view on the use of telemedicine in multiple sclerosis: a web-based survey (2021) (4)
Dystonia: Sparse Synapses for D2 Receptors in Striatum of a DYT1 Knock-out Mouse Model (2020) (4)
Not just a Snapshot: An Italian Longitudinal Evaluation of Stability of Gut Microbiota Findings in Parkinson’s Disease (2022) (4)
Rotigotine effect on sleep in a de novo Parkinson's Disease patient affected by periodic limb movement disorder. (2015) (4)
Pitolisant for treating narcolepsy comorbid with Parkinson's disease. (2020) (4)
Bilateral thalamic stroke due to nasal ephedrine and naphazoline use (2015) (4)
Neurotensin receptors inhibit mGluR I responses in nigral dopaminergic neurons via a process that undergoes functional desensitization by G-protein coupled receptor kinases (2019) (4)
0605 CONTINUOUS POSITIVE AIRWAY PRESSURE TREATMENT MAY RESTORE OPTIC NERVE FUNCTION IN PATIENTS AFFECTED BY OBSTRUCTIVE SLEE APNEA (2017) (4)
Tranylcypromine, but not moclobemide, prolongs the inhibitory action of dopamine on midbrain dopaminergic neurons: An in vitro electrophysiological study (2000) (4)
Diabetes mellitus contributes to higher cerebrospinal fluid tau levels selectively in Alzheimer's disease patients with the APOE4 genotype (2021) (4)
Potential Clinical Role of Prokineticin 2 (PK2) in Neurodegenerative Diseases (2022) (4)
Could the New Anti-CGRP Monoclonal Antibodies Be Effective in Migraine Aura? Case Reports and Literature Review (2022) (4)
Validation of the Italian version of the PSP Quality of Life questionnaire (2019) (4)
Protease-activated receptor 1 (PAR1) inhibits synaptic NMDARs in mouse nigral dopaminergic neurons. (2020) (3)
Seasonality of restless legs syndrome: symptom variability in winter and summer times. (2019) (3)
Actions of the sodium channel inhibitor 202W92 on rat midbrain dopaminergic neurons (2003) (3)
18F-FDG PET, cognitive functioning, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment (2022) (3)
Constipation distinguishes different clinical-biochemical patterns in de novo Parkinson's disease. (2022) (3)
Neurotrophins as Therapeutic Agents for Parkinson’s Disease; New Chances From Focused Ultrasound? (2022) (3)
A2A Receptor Dysregulation in Dystonia DYT1 Knock-Out Mice (2021) (3)
Chapter 25 Oxidative Stress in Stroke Pathophysiology (2009) (3)
Obstructive sleep apnoea is associated with early but possibly modifiable Alzheimer's Disease changes (2017) (3)
New revolution in the assessment of cerebrospinal fluid orexin‐A: Enzyme‐linked immunosorbent assay! (2019) (3)
Trace Amines Depress Gabab Response In Dopaminergic Neurons By Inhibiting Girk Channels (2005) (3)
Evidence in favour of GABA as an inhibitory transmitter in the rat striatum. (1981) (3)
Effects of melatonin prolonged-release on both sleep and motor symptoms in Parkinson’s disease: a preliminary evidence (2022) (3)
Temperature sensitivity of dopaminergic neurons of the substantia nigra pars compacta: involvement of TRP channels (2005) (3)
Perampanel may represent an effective treatment for the prevention of migraine comorbid with epilepsy (2021) (3)
Depressive symptoms in patients with epilepsy and clinically associated features in a single tertiary center (2021) (3)
N‐ethyl lidocaine (QX‐314) protects striatal neurons against ischemia: An in vitro electrophysiological study (2010) (3)
Actions of Levodopa on rat substantia nigra zona compacta neurons (1992) (3)
Lacosamide in the Management of Behavioral Symptoms in Frontotemporal Dementia: A 2-Case Report. (2018) (3)
MicroRNA expression is dysregulated in narcolepsy: a new evidence? (2015) (3)
Effects of epilepsy treatment on sleep architecture and daytime sleepiness: An evidence‐based review of objective sleep metrics (2014) (3)
Electrophysiological Characterization of Novel Effects of the Uptake-2 Blocker Decynium-22 (D-22) on Dopaminergic Neurons in the Substantia Nigra Pars Compacta (2019) (3)
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy (2019) (3)
Levetiracetam, lamotrigine and carbamazepine: which monotherapy during pregnancy? (2021) (2)
Upregulation of Ca2+-binding proteins contributes to VTA dopamine neuron survival in the early phases of Alzheimer’s disease in Tg2576 mice (2022) (2)
Author response: Early structural and functional plasticity alterations in a susceptibility period of DYT1 dystonia mouse striatum (2018) (2)
Basic research in substantia nigra and ventral tegmental area: clinical implications. (1995) (2)
Pattern of Mitochondrial Respiration in Peripheral Blood Cells of Patients with Parkinson’s Disease (2022) (2)
Early‐life social stress induces permanent alterations in plasticity and perineuronal nets in the mouse anterior cingulate cortex (2022) (2)
Alexithymia, impulsiveness, emotion, and eating dyscontrol: similarities and differences between narcolepsy type 1 and type 2 (2022) (2)
Nocturnal Hypoxia and Sleep Fragmentation May Drive Neurodegenerative Processes: The Compared Effects of Obstructive Sleep Apnea Syndrome and Periodic Limb Movement Disorder on Alzheimer's Disease Biomarkers. (2022) (2)
Perampanel effectiveness and tolerability in patients with epilepsy at long-term follow-up (2021) (2)
EVIDENCE FOR A NEUROMODULATORY ROLE OF DOPAMINE IN RAT STRIATAL NEURONS (1984) (2)
Distortion Product Otoacoustic Emissions and Their Suppression as Predictors of Peripheral Auditory Damage in Migraine: A Case-Control Study (2021) (2)
Clinical course of paroxysmal dyskinesias throughout pregnancy. (2020) (2)
CSF levels of the endocannabinoid anandamide are reduced in patients with untreated narcolepsy type 1: a pilot study. (2020) (2)
Dopamine: Cellular Actions (2009) (2)
Multiple sleep latency test may be not sensitive in obstructive sleep apnea with comorbid narcolepsy revealed by low cerebrospinal fluid orexin levels. (2014) (2)
Long-Term Depression of Striatal DA Release Induced by mGluRs via Sustained Hyperactivity of Local Cholinergic Interneurons (2021) (2)
Using a Video Device and a Deep Learning-Based Pose Estimator to Assess Gait Impairment in Neurodegenerative Related Disorders: A Pilot Study (2022) (2)
Refractory restless legs syndrome remitting after dual kidney transplantation. (2015) (2)
What substance P might tell us about the prognosis and mechanism of Parkinson's disease? (2021) (2)
The evolving role of quantitative actigraphy in clinical sleep medicine. (2023) (2)
Role of D1 and D2 Dopamine Receptors in the Mammalian Striatum: Electrophysiological Studies and Functional Implications (1987) (2)
Hydrogen sulphide "a double-faced Janus" in amyotrophic lateral sclerosis (ALS) (2015) (2)
Serum Substance P Is Increased in Parkinson's Disease and Correlates with Motor Impairment (2021) (2)
Commentary: Sleep Changes without Medial Temporal Lobe or Brain Cortical Changes in Community-Dwelling Individuals with Subjective Cognitive Decline (2017) (2)
The Retinal Posterior Pole in Early Parkinson’s Disease: A Fundus Perimetry and SD-OCT Study (2021) (2)
Subjective sleep disorders and daytime sleepiness in patients with restrictive type anorexia nervosa and effects on quality of life: a case–control study (2021) (1)
Targeting Synaptic Dysfunction in Alzheimer’s Disease Therapy (2012) (1)
The midbrain slice preparation. An in vitro model to select potential anti-parkinsonian drugs? (2008) (1)
Interleukin-1β Promotes Long-Term Potentiation in Patients with Multiple Sclerosis (2013) (1)
The actigraphic documentation of circadian sleep-wake rhythm dysregulation in myotonic dystrophy type 1. (2021) (1)
Ambra1 Shapes Hippocampal Inhibition/Excitation Balance: Role in Neurodevelopmental Disorders (2018) (1)
Sleep-wake cycle in the Kennedy's disease: a controlled polysomnographic study and self-reported questionnaires (2012) (1)
Derivation and Validation of a Phenoconversion‐Related Pattern in Idiopathic Rapid Eye Movement Behavior Disorder (2022) (1)
Cognitive functioning, cerebrospinal fluid Alzheimer's disease biomarkers and cerebral glucose metabolism in late‐onset epilepsy of unknown aetiology: A prospective study (2022) (1)
[A case of cerebral stroke caused by a spontaneous dissection of the internal carotid with rapid resolution]. (1990) (1)
Movement disorders in primary central nervous system lymphoma: two unreported cases and a review of literature (2021) (1)
Basic Electrophysiology and Possible New Therapeutic Approaches to Movement Disorders (1994) (1)
How Comorbidity Reflects on Cerebrospinal Fluid Biomarkers of Neurodegeneration in Aging (2021) (1)
Intermittent Short Sleep May Contribute to Orexinergic Signaling Dysregulation in Alzheimer's Disease. (2017) (1)
Determinants of approved acetylcholinesterase inhibitor response outcomes in Alzheimer’s disease: relevance for precision medicine in neurodegenerative diseases (2022) (1)
Complex Rearrangement of the Entire Retinal Posterior Pole in Patients with Relapsing Remitting Multiple Sclerosis (2021) (1)
Design of an Innovative Methodology for Cerebrospinal Fluid Analysis: Preliminary Results (2021) (1)
Morpho‐Functional Changes of Nigral Dopamine Neurons in an α‐Synuclein Model of Parkinson's Disease (2022) (1)
Spontaneous Depolarizing Synaptic Potentials in the Neostriatum (1991) (1)
Extrastriatal dopaminergic and serotonergic pathways in Alzheimer’s disease: A 123I‐FP‐CIT study (2020) (1)
Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population: further data and comments (2017) (1)
Effects of Trace Amines on the Dopaminergic Mesencephalic System (2016) (1)
Efficacy and safety of lacosamide in the treatment of status epilepticus in a patient with comorbidities (2021) (1)
Spasticity as an ictal pattern due to excitotoxic upper motor neuron damage (2012) (1)
Substance P and Prokineticin-2 are overexpressed in olfactory neurons and play differential roles in persons with persistent post-COVID-19 olfactory dysfunction (2022) (1)
Lacosamide as add-on treatment of focal symptomatic epilepsy in a patient with alcoholic liver cirrhosis (2014) (1)
Periodic sharp wave complexes identify a distinctive phenotype in Creutzfeldt-Jacob disease (2022) (1)
Interplay between the catecholaminergic enzymatic axis and neurodegeneration/neuroinflammation processes in the Alzheimer's disease continuum (2023) (1)
Neuropsychiatric, neuropsychological, and neuroimaging features in isolated REM sleep behavior disorder: The importance of MCI. (2022) (1)
Intermittent short sleep may contribute to orexinergic signaling dysregulation in Alzheimer's Disease. (2016) (1)
Fampridine improves acute optic neuritis contributing to a long-lasting recovery of nerve function (2021) (1)
Comments on: "Complementary and alternative therapies for restless legs syndrome: An evidence-based systematic review". (2018) (1)
Non-motor symptoms burden in motor-fluctuating patients with Parkinson’s disease may be alleviated by safinamide: the VALE-SAFI study (2022) (1)
Erratum: Continuous positive airway pressure treatment increases serum Vitamin D levels in male patients with obstructive sleep apnea (Journal of Clinical Sleep Medicine (2015) 11:6 (603-607)) (2015) (1)
Biological Mechanism-based Neurology and Psychiatry: a BACE1/2 and Downstream Pathway Model. (2021) (1)
Cerebellar white matter disruption in AD patients: a Diffusion Tensor Imaging study (2020) (1)
Effect of dopamine on the threshold of the voltage-dependent ionic channels in the rat brain. (1984) (1)
D2 Receptor Activation Increases Potassium Conductance in Substantia Nigra Zona Compacta Neurones in vitro (1988) (1)
Neuropsychiatric, neuropsychological, and neuroimaging features in isolated REM sleep behavior disorder: does MCI matter? (2022) (0)
Sleep architecture in REM-OSA and NREM-OSA: analogies and differences (2022) (0)
Inhibition of hippocampal plasticity in rats performing contrafreeloading for water under repeated administrations of pramipexole (2015) (0)
Transient upregulation of translational efficiency in prodromal Tg2576 mice precipitates AD symptoms (2019) (0)
Both Motor and Non-Motor Fluctuations Matter in the Clinical Management of Patients with Parkinson’s Disease: An Exploratory Study (2023) (0)
ROLE OF Dl and D2 DOPAMINE RECEPTORS IN THE MAMMALIAN STRIATUM (1987) (0)
Correlation between epileptiform activity and cerebrospinal fluid biomarkers in Alzheimer's disease (2013) (0)
Transmitter amino acid receptors: structures, transduction and models for drug development (1993) (0)
D-aspartate exerts an opposing role upon age-dependent NMDAR-related synaptic plasticity and memory decay (2008) (0)
Adult onset sporadic chorea: A single-centre retrospective study (2021) (0)
Identification and validation of a brain glucose metabolism conversion pattern in idiopathic REM Behaviour Disorder (2022) (0)
Seasonality of restless legs syndrome: symptoms variability in winter and summer times (2019) (0)
The excitatory action of morphine on rat cortical neurons is mediated by a post-synaptic mechanism. (1985) (0)
Hippocampal Slices Dendritic Spine Density and LTP Induction in Cultured (2015) (0)
1138 HYPOTHALAMIC DYSFUNCTION IS RELATED TO SLEEP IMPAIRMENT AND CEREBROSPINAL-FLUID BIOMARKERS IN ALZHEIMER’S DISEASE (2017) (0)
Progressive Supranuclear Palsy Quality of Life Scale--Italian Version (2020) (0)
Sudomotor dysfunction in moderate to severe obstructive sleep apnea syndrome and the effects of CPAP treatment (2022) (0)
Shaping the course of early-onset Parkinson's disease: insights from a longitudinal cohort. (2023) (0)
Moderate-severe obstructive sleep apnea and the risk for preclinical Alzheimer's disease biomarkers changes (2017) (0)
Clinical and radiological phenotype of multiple sclerosis associated to coeliac disease: Monocentric experience (2021) (0)
31. Does continuous positive airway pressure treatment affect autonomic nervous system in patients with severe obstructive sleep apnea? (2017) (0)
The effect of lacosamide monotherapy on sleep architecture in patients with epilepsy: a preliminary evidence (2023) (0)
18F-FDG PET, cognitive, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment (2022) (0)
Neuropathology of the Basal Ganglia in SNCA Transgenic Rat Model of Parkinson’s Disease: Involvement of Parvalbuminergic Interneurons and Glial-Derived Neurotropic Factor (2022) (0)
OPTH_A_323944 4005..4014 (2021) (0)
“Creutzfeldt-Jacob disease or other rapidly progressive dementia? Diagnostic and prognostic value of EEG, brain MRI and CSF features” (2021) (0)
Actions ofcocaine on ratdopaminergic neurones invitro (1990) (0)
Sleep–wake cycle and daytime sleepiness in patients with epilepsy after initiating perampanel as adjunctive therapy (2022) (0)
Letter re: Prolonged sleep duration as a marker of early neurodegeneration predicting incident dementia (2017) (0)
Assessing blink reflex circuits in patients with REM behaviour disorder and patients with Parkinson’s disease (2022) (0)
CSF level of anti-aging protein Α-klotho is inversely associated with Α-synuclein in Parkinson's disease patients (2021) (0)
Treating TB human neuroectodermal cell line with retinoic acid induces the appearance of neuron-like voltage-gated ionic currents (2019) (0)
Correction to: Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer’s disease course (2020) (0)
Dopaminergic agonists and l-dopa (2009) (0)
Dysregulation Of beta-amyloid metabolism in narcolepsy (2019) (0)
Cerebrospinal Fluid sTREM-2, GFAP, and β-S100 in Symptomatic Sporadic Alzheimer's Disease: Microglial, Astrocytic, and APOE Contributions Along the Alzheimer's Disease Continuum. (2023) (0)
Sex hormones differentially contribute to Parkinson's disease in males: a multimodal biomarker study. (2023) (0)
Calcineurin Inhibition Rescues Early Synaptic Plasticity Deficits in a Mouse Model of Alzheimer’s Disease (2013) (0)
Parkinsonism Carers Quality of Life--Italian Version (2020) (0)
Compliance with levodopa-carbidopa intestinal gel in a selected population in central south Italy: Beyond sex, a possible gender effect. (2020) (0)
DOPAMINERGIC RECEPTORS IN HIPPOCAMPUS: AN “IN VITRO” ELECTROPHYSIOLOGICAL STUDY (1984) (0)
A2A receptors in mouse model of DYT1 primary dystonia (2021) (0)
Electrophysiological responses of basal ganglia neurons to O2 deprivation: an in vitro study (1996) (0)
Correction to: Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer’s disease course (2020) (0)
Potential therapeutic usefulness of hydrogen peroxide in conditions of brain ischemia. (2008) (0)
Basal ganglia disorders. An electrophysiologic approach. (1996) (0)
Sudomotor and cardiovascular autonomic function in de novo Parkinson's disease assessed by sudoscan and cardiovascular reflexes (2021) (0)
Familial Dysautonomia (Riley-Day Syndrome) (2019) (0)
the rat substantia nigra Protective role of hydrogen peroxide in oxygen-deprived dopaminergic neurones of (2007) (0)
Characterization of GABA and Glycine Actions on Substantia Nigra Zona Compacta Neurons (1991) (0)
Differences in CSF Biomarkers Profile of Patients with Parkinson's Disease Treated with MAO-B Inhibitors in Add-On. (2022) (0)
Obstructive sleep apnoea and bone health (2016) (0)
Functional Correlates of Microglial and Astrocytic Activity in Symptomatic Sporadic Alzheimer’s Disease: A CSF/18F-FDG-PET Study (2023) (0)
Cerebrospinal-fluid biomarkers and blood-brain barrier alteration may be useful to predict the phenoconversion of patients with idiopathic/isolated REM sleep behaviour disorder (2022) (0)
Abdominal myoclonus in a patient implanted with spinal cord stimulator (2022) (0)
P-11-37 Actions of the anticonvulsant felbamate on striatal neurons (1995) (0)
In vivo human molecular neuroimaging of dopaminergic vulnerability along the Alzheimer’s disease phases (2021) (0)
Movement disorders related to primary central nervous system lymphoma: Two novel cases and a literature review (2021) (0)
ON THE POTASSIUMCONDUCTANCE INCREASEACTIVATEDBY GABABAND DOPAMINE D2RECEPTORS INRAT SUBSTANTIANIGRA NEURONES (2011) (0)
Sleep-wake distribution and circadian pattern of focal subclinical seizures (2021) (0)
Correlations between systemic comorbidity burden and CSF biomarkers of neurodegeneration in aging individuals (2021) (0)
Investigating biomarkers for predicting the conversion to alpha-synucleinopathies in patients affected by REM sleep behavior disorder: a comprehensive analysis of clinical, neuropsychological, neuroimaging, and cerebrospinal-fluid data (2017) (0)
Perampanel effects on cognition and quantitative EEG in patients with epilepsy (2021) (0)
Changes in Ventral Midbrain opaminergic Neurons Resulting from / )-3 , 4-Methylenedioxymethamphetamine MDMA — “ Ecstasy ” ) (2007) (0)
Neurochemistry of the emotions: behavioural and physiological correlates of catecholaminergic systems (1989) (0)
In Alzheimer's disease sleep impairment is correlated with cognitive decline, increased tau and decreased beta-amyloid CSF levels (2013) (0)
Highly purified cannabidiol improves stability and postural tone in adult patients with Lennox-Gastaut Syndrome: a case series. (2023) (0)
Astrocyte-Dependent Vulnerability to Excitotoxicity in Spermine Oxidase-Overexpressing Mouse (2015) (0)
Acute reduction of β band functional connectivity induced by STN-DBS in patients with Parkinson’s disease (2023) (0)
Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer’s disease course (2020) (0)
Association between hearing sensitivity and dopamine transporter availability in Parkinson’s disease (2023) (0)
Imaging dopamine system transporter activity and connectivity in Alzheimer’s dementia (2020) (0)
Metabotropic agonists reduce the excitatory transmission onto rat midbrain dopaminergic neurons in vitro (1996) (0)
Abstracts of the 6th Meeting of the Neapolitan Brain Group (2018) (0)
Physical activity contradictorily affects bone mineral density in obstructive sleep apnea patients at different ages. (2017) (0)
Tissue degeneration in ALS affected spinal cord evaluated by Raman spectroscopy (2018) (0)
Cognitive decline in late-onset epilepsy of undefined etiology: A longitudinal cohort study (2021) (0)
Sleep inertia in hypersomnias of central origin: importance of depression and sleep architecture (2022) (0)
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis (2016) (0)
Insulin Receptor β-Subunit Haploinsufficiency Impairs Hippocampal Late-Phase LTP and Recognition Memory (2012) (0)
Continuous positive airway pressure treatment may restore optic nerve function in patients affected by obstructive sleep apnoea (2017) (0)
STN-DBS Induces Acute Changes in β-Band Cortical Functional Connectivity in Patients with Parkinson’s Disease (2022) (0)
Sleep architecture in drug‐naïve adult patients with epilepsy: Comparison between focal and generalized epilepsy (2022) (0)
New Insights Into mGluRs Function in the Substantia Nigra Pars Compacta (2002) (0)
Neuro-physiological characterization of opioid peptide actions on neurohumoral transmission in the mammalian central nervous system (1986) (0)
Gut microbiota dysbiosis in Parkinson's disease patients: Early feature and biomarker of disease progression? (2021) (0)
Trace Amines Cause More than One Effect on Dopaminergic Neurons (2005) (0)

This paper list is powered by the following services:

Nicola Biagio Mercuri's Academic­Influence.com Rankings

Why Is Nicola Biagio Mercuri Influential?

Nicola Biagio Mercuri's Published Works

Published Works

Nicola Biagio Mercuri's AcademicInfluence.com Rankings